Skip to main content
. 2022 Aug 16;5(3):339–361. doi: 10.3138/canlivj-2021-0029

Supplemental Table 4:

The top three cost components by phase-of-care and HBV group (CAD$)

No HBV-related complication HBV-related complication prior to or on index date HBV-related complication post index date
Pre-diagnosis care

n = 29,825

n = 3,098

n = 4,408

Outpatient laboratory tests, $1

Outpatient medication, $17

Dialysis clinic visits, $3%*

Dialysis clinic visits, $0%*

Hospital based outpatient clinic visits, $9

Complex continuing care, $2%*

Chemotherapy drugs, $0%*

Dialysis clinic visits, $2%*

Outpatient laboratory tests, $1

Initial care

n = 29,717

n = 2,869

n = 4,137

Inpatient hospitalization, $45

Inpatient hospitalization, $579

Inpatient hospitalization, $146

Physician services, $39 Physician services, $154 Physician services, $90
Dialysis clinic visits, $17 Outpatient medication, $98 Hospital based outpatient clinic visits, $40
Continuing care n = 29,637 n = 2,783 n = 2,893
Outpatient medication, $12 Inpatient hospitalization, $145 Outpatient medication, $43
Dialysis clinic visits, $11 Outpatient medication, $97 Physician services, $40
Inpatient hospitalization, $9 Physician services, $45 Hospital based outpatient clinic visits, $28
HBV-related NA complication NA n = 4,264
Inpatient hospitalization, $457
Physician services, $177
Hospital based outpatient clinic visits, $115
Continuing care NA for HBV-related complication NA NA n = 4,162
Outpatient medication, $96
Inpatient hospitalization, $65
Physician services, $37
Final care n = 685 n = 661 n = 525
Inpatient hospitalization, $2,987 Inpatient hospitalization, $2,747 Inpatient hospitalization, $1,855
Dialysis clinic visits, $485 Physician services, $410 Physician services, $468
Physician services, $365 Hospital based outpatient clinic visits, $126 Dialysis clinic visits, $241

* 95% CI crossed zero

NA = Not applicable